<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<oembed>
  <author_name>marfan-info</author_name>
  <author_url>https://blog.hatena.ne.jp/marfan-info/</author_url>
  <blog_title>海外マルファン情報 | Global Marfan Updates</blog_title>
  <blog_url>https://marfan-info.hatenablog.com/</blog_url>
  <categories>
    <anon>オンラインセミナー</anon>
    <anon>薬</anon>
  </categories>
  <description>Living with Risk 7:10-8:08 There is also some other good news in 2020. This was a meta-analysis looking at the use of medications essentially showing that angiotensin receptor blockers like losartan and irbesartan slowed the rate of aortic progression when they were compared to placebo and there was…</description>
  <height>190</height>
  <html>&lt;iframe src=&quot;https://hatenablog-parts.com/embed?url=https%3A%2F%2Fmarfan-info.hatenablog.com%2Fentry%2F2022%2F01%2F29%2F115726&quot; title=&quot;リスクと生きる　～ARBとβ遮断薬に関する研究～ - 海外マルファン情報 | Global Marfan Updates&quot; class=&quot;embed-card embed-blogcard&quot; scrolling=&quot;no&quot; frameborder=&quot;0&quot; style=&quot;display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;&quot;&gt;&lt;/iframe&gt;</html>
  <image_url></image_url>
  <provider_name>Hatena Blog</provider_name>
  <provider_url>https://hatena.blog</provider_url>
  <published>2022-01-29 11:57:26</published>
  <title>リスクと生きる　～ARBとβ遮断薬に関する研究～</title>
  <type>rich</type>
  <url>https://marfan-info.hatenablog.com/entry/2022/01/29/115726</url>
  <version>1.0</version>
  <width>100%</width>
</oembed>
